Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126146951 | 12614695 | 1 | I | 20160720 | 20160802 | 20160802 | EXP | JP-TEVA-681478ISR | TEVA | TSUJI?T, MIURA?M, YANAI?M, ITAMI?H, ISHII?Y, AKIMOTO?M ET AL. DE NOVO PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IGG DEPOSITS OF THE IGG1K SUBTYPE IN A KIDNEY ALLOGRAFT. NEPHROLOGY.2016; 21(1): 44-47. | 45.00 | YR | M | Y | 0.00000 | 20160802 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126146951 | 12614695 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Y | 65457 | |||||||||||
| 126146951 | 12614695 | 2 | SS | TACROLIMUS. | TACROLIMUS | 1 | Y | 0 | 7 | MG | |||||||||
| 126146951 | 12614695 | 3 | SS | TACROLIMUS. | TACROLIMUS | 1 | Y | 0 | 4 | MG | |||||||||
| 126146951 | 12614695 | 4 | SS | EVEROLIMUS | EVEROLIMUS | 1 | U | 0 | 2 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126146951 | 12614695 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126146951 | 12614695 | Glomerulonephritis proliferative | |
| 126146951 | 12614695 | Post transplant lymphoproliferative disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |